Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

Janssen Discontinued Levaquin Production as Concerns Over Fluoroquinolone Side Effects Grew

Johnson & Johnson’s Janssen Pharmaceuticals unit discontinued production of Levaquin in December 2017, amid growing concerns over the serious side effects and complications potentially associated with the use of fluoroquinolone antibiotics. The decision affected both oral and injectable versions of … Continue reading

Transvaginal Mesh Complications Lead to Virtual Ban at U.K. Hospitals

Regulators in the U.K. have effectively banned the use of transvaginal mesh in hospitals run by the National Health Services (NHS) in an effort to lessen the risk “life-changing and life-threatening injuries” to women. Decision a Major Victory for U.K. … Continue reading

Rat Study Suggests Gadolinium Injections May Leave Deposits in Brain

A recent study involving rats is adding to concerns that toxic gadolinium deposits may accumulate in the body – specifically the brain – following the administration of certain MRI contrast dyes. FDA Gadolinium Retention Warning Gadolinium-based MRI contrast dyes are … Continue reading

Johnson & Johnson Hit with $4.7 Billion Talcum Powder Ovarian Cancer Verdict

A Missouri jury has ordered Johnson & Johnson to pay a total of $4.7 billion to 22 women or their survivors, after finding that the company failed to warn consumers that long-term use of the its popular talcum powder products … Continue reading

FDA Announces New Side Effects Warnings for Levaquin, Other Fluoroquinolone Antibiotics

Levaquin and other fluoroquinolone antibiotics have been associated with serious mental health side effects, as well as severe blood sugar disturbances, prompting the U.S. Food & Drug Administration (FDA) to update the drugs’ prescribing information yet again. What is the … Continue reading

Thousands of Risperdal Lawsuits at Stake in Upcoming Appeal

The fate of thousands of Risperdal lawsuits is now in the hands of the Pennsylvania Supreme Court, which has agreed to hear an appeal on whether some cases should be time barred. Trial Court Set June 30, 2009 for Filing … Continue reading

Pennsylvania Judge Urges Appeals Court to Uphold $70 Million Risperdal Lawsuit Verdict

A Pennsylvania judge has urged the state’s Superior Court to uphold a $70 million verdict awarded to a Risperdal gynecomastia plaintiff in 2016. Verdict Is Larges Awarded in Pennsylvania Risperdal Litigation The case was the fifth to be tried in … Continue reading

Study Suggests Gadolinium MRI Contrast Dyes Accumulate in Marine Ecosystems

A group of researchers have suggested that gadolinium MRI contrast dyes are accumulating in certain marine ecosystems, which could ultimately have consequences for human health. Gadolinium is used in MRI contrast dyes to improve the visibility of organs, tumors, and … Continue reading

Taxotere Lawsuit News: Federal Litigation to Convene Five Bellwether Trials Starting May 2019

The federal court overseeing thousands of Taxotere lawsuits filed over the chemotherapy drugs’ alleged potential to cause permanent hair loss will convene five bellwether trials beginning in May 2019. According to an Order issued in the U.S. District Court, Eastern … Continue reading

Pennsylvania Appeals Court Upholds $12.8 Million Transvaginal Mesh Verdict Against Ethicon

The Pennsylvania Superior Court has upheld a $12.8 Million verdict awarded to a woman who suffered painful complications following implantation of a transvaginal mesh device manufactured by Johnson & Johnson’s Ethicon, Inc. subsidiary. Yesterday’s decision marks the first time the … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest